| Bioactivity | (Ala13)-Apelin-13 is a potent apelin receptors (APJ) antagonist. (Ala13)-Apelin-13 inhibits gastric motility through vagal cholinergic pathway[1]. |
| In Vivo | (Ala13)-Apelin-13 (1-300 pmol/60 nl；显微注射到 DVC 中) 以剂量依赖性方式降低大鼠的胃张力和胃动力[1]。 Animal Model: |
| Name | (Ala13)-Apelin-13 |
| CAS | 568565-11-7 |
| Sequence | Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Ala |
| Shortening | QRPRLSHKGPMPA |
| Formula | C63H107N23O16S |
| Molar Mass | 1474.73 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bülbül M, et al. Apelin-13 inhibits gastric motility through vagal cholinergic pathway in rats. Am J Physiol Gastrointest Liver Physiol. 2018 Feb 1;314(2):G201-G210. |
(Ala13)-Apelin-13
CAS: 568565-11-7 F: C63H107N23O16S W: 1474.73
(Ala13)-Apelin-13 is a potent apelin receptors (APJ) antagonist. (Ala13)-Apelin-13 inhibits gastric motility through vag
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.